MedPath

Impact of Chronic Exposure to Radiofrequency Electromagnetic Fields on Neurophysiological Development in the Preterm Neonate

Not Applicable
Active, not recruiting
Conditions
Preterm Infant
Exposure to Radiofrequency
Interventions
Other: Parental questionnaire
Other: Daily continuous recording of radiofrequency exposure levels
Other: Follow-up of daily infants environmental and clinical parameters
Other: Nocturnal polysomnography
Diagnostic Test: cerebral hemodynamics
Diagnostic Test: activity of the autonomic nervous system
Registration Number
NCT03928457
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

The massive use of highly technological devices in Neonatal Intensive Care Units may expose preterm neonates to electromagnetic fields, especially radiofrequencies, at low doses but continuously and chronically. Strikingly, the effect of long-term exposure to radiofrequencies on the neurophysiological development of preterm neonates has never been studied so far. The only studies on the impact of chronic exposure to radiofrequencies have been conducted in animals or adult humans, whereas preterm infants may be particularly vulnerable due to increased penetration of radiofrequency waves into the brain during a crucial period of neurodevelopment. The present project will aim at 1) quantifying individual levels of chronic exposure (during 6 weeks) to which preterm neonates are subjected during their stay in the Neonatal Intensive Care Unit, 2) following the evolution of the thermal environment and of the clinical parameters of the neonates after birth, 3) identifying potential alterations of neurophysiological activity (sleep, cerebral hemodynamics, autonomic nervous activity) which will be correlated to actual levels of chronic RF-EMF (radiofrequency electromagnetic fields) exposure.

Detailed Description

Preterm infants are potentially exposed to chronic, low levels of electromagnetic fields, especially radiofrequencies, while hospitalized in neonatal intensive care units. Moreover, they may be particularly vulnerable due to increased penetration of radiofrequency waves into the brain during a crucial period of neurodevelopment. This study will aim at evaluating the influence of radiofrequency electromagnetic fields exposure on the neurophysiological development in preterm neonates.

The first part of this study will be devoted to the measurement of environmental electromagnetic fields in order to map their distribution in the paediatric department. From birth and during 6 weeks, the investigators will perform, for each child, a continuous measurement of radiofrequencies at the incubator level. Infants' clinical data (medical history, nutrition, morphology...) and the evolution of the thermal environment in incubators (air and body temperatures) will also be continually monitored. At 3 and 6 weeks of life, the investigators will investigate sleep (EEG, EOG), cerebral hemodynamics (near-infrared spectroscopy), autonomic nervous system activity (ECG, heart rate variability) and various cardiorespiratory parameters (SpO2, apnoea, bradycardia) thanks to a night-time polysomnography.

The impact of radiofrequency electromagnetic fields will be evaluated by analyses of the relationship between exposure levels and the various parameters extracted from the neurophysiological investigation phase.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • preterm neonates born at 26 to 34 weeks of gestational age
  • signed written informed consent form
Exclusion Criteria
  • infants infected
  • infants suffering from neurological disorders
  • serious heart, respiratory, digestive or metabolic diseases
  • infants born from mothers aged less than 18 years old or deprived of their parental rights
  • non covered by national health insurance

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
preterm neonatecerebral hemodynamics-
preterm neonateDaily continuous recording of radiofrequency exposure levels-
preterm neonateactivity of the autonomic nervous system-
preterm neonateParental questionnaire-
preterm neonateFollow-up of daily infants environmental and clinical parameters-
preterm neonateNocturnal polysomnography-
Primary Outcome Measures
NameTimeMethod
total sleep time in hoursfrom birth to 6 weeks of life

Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

relative durations of sleep states in hoursfrom birth to 6 weeks of life

Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

sleep state change frequencyfrom birth to 6 weeks of life

Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

absolute durations of sleep states in hoursfrom birth to 6 weeks of life

Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

Secondary Outcome Measures
NameTimeMethod
Autonomic nervous system activityfrom birth to 6 weeks of life

Autonomic nervous system activity will be determined by measuring means of a heart rate variability

apnea frequencyfrom birth to 6 weeks of life

cardiorespiratory parameters (apnea, bradycardia, desaturation) will be determined

desaturation frequencyfrom birth to 6 weeks of life

cardiorespiratory parameters (apnea, bradycardia, desaturation) will be determined

Cerebral hemodynamicsfrom birth to 6 weeks of life

Cerebral hemodynamics will be determined by measuring regional cerebral oxygen saturation

bradycardia frequencyfrom birth to 6 weeks of life

cardiorespiratory parameters (apnea, bradycardia, desaturation) will be determined

Evolution of the anthropomorphic characteristics of the subjectsfrom birth to 6 weeks of life

anthropomorphic characteristics of the subjects are height and weight. Weight and height will be combined to report BMI in kg/m\^2.

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath